Liquid Chromatography-Mass Spectrometry (LC-MS) is an important tool in the field of bioanalysis. Presented at the American Association of Pharmaceutical Scientists National Biotechnology Conference, this presentation highlights 3 key reasons LC-MS should be used for protein bioanalysis, as well as the key differences between protein therapeutics and protein biomarkers. You'll also learn about the advantages and disadvantages of protein bioanalysis by LC-MS through insightful case studies.
At IQVIA Laboratories, our scientists have extensive bioanalytical method development and liquid chromatography - tandem mass spectrometry expertise to not only meet your analytical needs, but to bring insights to the table that enhance the drug development process. Download the presentation to learn more.
Speaker:
Stephen Lowes, Ph.D., Senior Scientific Director, Bioanalysis and ADME Services
Related Insights
ADME Services
Accelerating your drug discovery, preclinical and clinical programs
Bioanalytical Automation of Samples
Taking an assay from bench to an automated platform
Automation within an ADME Laboratory
Taking an assay from bench to an automated platform
Bioanalytical Automation of Samples
Taking an assay from bench to an automated platform
Developing Assays for Novel Drugs
Current science regarding hybrid assays, why they are considered the next "big thing," the technical challenges, and the regulatory impact of these assays.
Strategies for Effective Neutralizing Cell Based Assays in Early Immunogenicity Risk Assessment
Quantitative Assays for Peptides using LC-MS
Quantitative high-throughput analysis of peptide therapeutics and biomarkers to regulated bioanalytical standards
Hybrid Assays for Protein Bioanalysis
Combining immuno-affinity with liquid chromatography-mass spectrometry (LC-MS)
Absolute Bioavailability Analysis Using Stable Isotopes
A Liquid Chromatography-Tandem Mass Spectrometry Approach
Bioanalysis for Immuno Oncology with Mike Brown
I-O clinical development podcast series
